Literature DB >> 29700001

MVisAGe Identifies Concordant and Discordant Genomic Alterations of Driver Genes in Squamous Tumors.

Vonn Walter1,2,3, Ying Du4, Ludmila Danilova5,6, Michele C Hayward3, D Neil Hayes3,7.   

Abstract

Integrated analyses of multiple genomic datatypes are now common in cancer profiling studies. Such data present opportunities for numerous computational experiments, yet analytic pipelines are limited. Tools such as the cBioPortal and Regulome Explorer, although useful, are not easy to access programmatically or to implement locally. Here, we introduce the MVisAGe R package, which allows users to quantify gene-level associations between two genomic datatypes to investigate the effect of genomic alterations (e.g., DNA copy number changes on gene expression). Visualizing Pearson/Spearman correlation coefficients according to the genomic positions of the underlying genes provides a powerful yet novel tool for conducting exploratory analyses. We demonstrate its utility by analyzing three publicly available cancer datasets. Our approach highlights canonical oncogenes in chr11q13 that displayed the strongest associations between expression and copy number, including CCND1 and CTTN, genes not identified by copy number analysis in the primary reports. We demonstrate highly concordant usage of shared oncogenes on chr3q, yet strikingly diverse oncogene usage on chr11q as a function of HPV infection status. Regions of chr19 that display remarkable associations between methylation and gene expression were identified, as were previously unreported miRNA-gene expression associations that may contribute to the epithelial-to-mesenchymal transition.Significance: This study presents an important bioinformatics tool that will enable integrated analyses of multiple genomic datatypes. Cancer Res; 78(12); 3375-85. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29700001      PMCID: PMC6028011          DOI: 10.1158/0008-5472.CAN-17-3464

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.

Authors:  D G Johnson; K Ohtani; J R Nevins
Journal:  Genes Dev       Date:  1994-07-01       Impact factor: 11.361

2.  DNA copy number gains in head and neck squamous cell carcinoma.

Authors:  M Lin; L T Smith; D J Smiraglia; R Kazhiyur-Mannar; J C Lang; D E Schuller; K Kornacker; R Wenger; C Plass
Journal:  Oncogene       Date:  2006-03-02       Impact factor: 9.867

3.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

4.  Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.

Authors:  S J Smeets; B J M Braakhuis; S Abbas; P J F Snijders; B Ylstra; M A van de Wiel; G A Meijer; C R Leemans; R H Brakenhoff
Journal:  Oncogene       Date:  2006-04-20       Impact factor: 9.867

5.  Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis.

Authors:  Lin Ge; Matthew Smail; Wenxia Meng; Yu Shyr; Fei Ye; Kang-Hsien Fan; Xiaohong Li; Hong-Mei Zhou; Neil A Bhowmick
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

6.  Comprehensive genomic characterization of head and neck squamous cell carcinomas.

Authors: 
Journal:  Nature       Date:  2015-01-29       Impact factor: 49.962

7.  SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.

Authors:  Adam J Bass; Hideo Watanabe; Craig H Mermel; Soyoung Yu; Sven Perner; Roel G Verhaak; So Young Kim; Leslie Wardwell; Pablo Tamayo; Irit Gat-Viks; Alex H Ramos; Michele S Woo; Barbara A Weir; Gad Getz; Rameen Beroukhim; Michael O'Kelly; Amit Dutt; Orit Rozenblatt-Rosen; Piotr Dziunycz; Justin Komisarof; Lucian R Chirieac; Christopher J Lafargue; Veit Scheble; Theresia Wilbertz; Changqing Ma; Shilpa Rao; Hiroshi Nakagawa; Douglas B Stairs; Lin Lin; Thomas J Giordano; Patrick Wagner; John D Minna; Adi F Gazdar; Chang Qi Zhu; Marcia S Brose; Ivan Cecconello; Ulysses Ribeiro; Suely K Marie; Olav Dahl; Ramesh A Shivdasani; Ming-Sound Tsao; Mark A Rubin; Kwok K Wong; Aviv Regev; William C Hahn; David G Beer; Anil K Rustgi; Matthew Meyerson
Journal:  Nat Genet       Date:  2009-10-04       Impact factor: 38.330

8.  DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data.

Authors:  Keyan Salari; Robert Tibshirani; Jonathan R Pollack
Journal:  Bioinformatics       Date:  2009-12-22       Impact factor: 6.937

9.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nucleic Acids Res       Date:  2008-11-25       Impact factor: 16.971

10.  FADD the bad in head and neck cancer.

Authors:  Paul Dent
Journal:  Cancer Biol Ther       Date:  2013-08-15       Impact factor: 4.742

View more
  3 in total

1.  BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia.

Authors:  Khashayar Roohollahi; Yvonne de Jong; Govind Pai; Mohamad Amr Zaini; Klaas de Lint; Daoud Sie; Martin A Rooimans; Davy Rockx; Elizabeth E Hoskins; Najim Ameziane; Rob Wolthuis; Hans Joenje; Susanne I Wells; Josephine Dorsman
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

2.  High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures.

Authors:  Khashayar Roohollahi; Yvonne de Jong; Saskia E van Mil; Armida W M Fabius; Annette C Moll; Josephine C Dorsman
Journal:  Ophthalmol Sci       Date:  2022-06-20

3.  Genomic characterization of rare molecular subclasses of hepatocellular carcinoma.

Authors:  Jeffrey S Damrauer; Markia A Smith; Vonn Walter; Aatish Thennavan; Lisle E Mose; Sara R Selitsky; Katherine A Hoadley
Journal:  Commun Biol       Date:  2021-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.